BSX

Boston ScientificD

NYSE / Health Care Equipment & Services

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$155.00

+225.1% vs current

Most likely

Base case

60%

Probability

Target price

$115.00

+141.2% vs current

B-

Bear case

20%

Probability

Target price

$85.00

+78.3% vs current

AI sentiment snapshot

Latest data as of 2025-10-23

AI commentary

Market tone is cautiously constructive: investors reward clearer procedure-volume recovery and product momentum but penalize legal or regulatory headlines. Short-term volatility is driven by recall/litigation chatter while medium-term focus remains on product adoption and margin improvement [#PR-2025-10], [#10-Q].

RankAlpha Sentiment AI - 2025-10-23

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

-eventQuarterly earnings & guidanceMedium impact

Quarterly results and guidance will move shares; key readouts are procedure volumes, organic revenue, and margin trajectory [#10-Q], [#PR-2025-Q3].

-catalystLegal, recall or reimbursement shockHigh impact

Adverse legal rulings, major recalls, or reimbursement reductions could trigger sharp downside and multiple compression [#10-KpRisk], [#Legal-Update].

-catalystNew device approvals and launchesHigh impact

FDA approvals or faster commercial uptake of stents, pacing, and neuromodulation products could drive medium-term revenue upside [#FDA], [#PR-2025-06-15].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-10-23 • Updated nightlySource: Internal modelMethodology